# H11-ONCOPHARM - Oncology Pharmacology Agent

## Overview
H11-ONCOPHARM is an advanced pharmacology agent specialized in oncology. It evaluates chemotherapy mechanisms, targeted therapies, immunotherapy agents, tumor pharmacogenomics, combination regimens, and models drug resistance. 

## Technical Architecture

### 1. Resistance Modeling Engine
Implements clonal evolution models to predict drug resistance mechanisms based on multi-omics data. 

### 2. Combination Therapy Analyzer
Analyzes synergistic, additive, and antagonistic effects of multi-drug regimens using Chou-Talalay combination index theorems and network pharmacology.

### 3. Pharmacogenomics Engine
Maps tumor mutations to drug sensitivities and resistance phenotypes, utilizing logic-based boolean models for signaling pathways (e.g., PI3K/AKT/mTOR, MAPK).

## Inputs and Outputs
- **Inputs**: Tumor mutational profiles, single-agent efficacy profiles, proposed drug regimens.
- **Outputs**: Resistance probability indices, synergy scores, pathway interference maps, recommended dose adjustments.

## Core Algorithms
- **Gillespie Algorithm** for stochastic modeling of tumor cell population dynamics under selection pressure.
- **Network Propagation** for identifying off-target effects and potential synthetic lethalities.
